David Surguladze
- Co-authors
- Ruslan D. NovosiadlyGregory D. PlowmanStephen CastanedaKyla DriscollGerald E. HallYanxia LiPhilip W. IversenKarim A. Benhadji
- Topics
- Angiogenesis and VEGF in Cancer (5 papers)Cancer Research and Treatments (4 papers)Cancer, Hypoxia, and Metabolism (3 papers)
- Cited by
- OncologyImmunologyCancer Research
- Partner nations
- United StatesBelgium
In The Last Decade
David Surguladze
21 papers receiving 520 citations
Peers
Comparison fields: 5 of 69
- Oncology 290
- Molecular Biology 212
- Immunology 146
- Pulmonary and Respiratory Medicine 89
- Cancer Research 78
Countries citing papers authored by David Surguladze
This map shows the geographic impact of David Surguladze's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Surguladze with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Surguladze more than expected).
Fields of papers citing papers by David Surguladze
This network shows the impact of papers produced by David Surguladze. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Surguladze. The network helps show where David Surguladze may publish in the future.
Co-authorship network of co-authors of David Surguladze
This figure shows the co-authorship network connecting the top 25 collaborators of David Surguladze. A scholar is included among the top collaborators of David Surguladze based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Surguladze. David Surguladze is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 5 | |
| 2 | 1 | |
| 3 | 267 | |
| 4 | 1 | |
| 5 | 26 | |
| 6 | 1 | |
| 7 | 27 | |
| 8 | 1 | |
| 9 | 11 | |
| 10 | 16 | |
| 11 | 1 | |
| 12 | 14 | |
| 13 | 28 | |
| 14 | 1 | |
| 15 | 40 | |
| 16 | 6 | |
| 17 | Prioritization of EGFR/IGF-IR/VEGFR2 combination targeted therapies utilizing cancer models. | 8 |
| 18 | 34 | |
| 19 | 32 | |
| 20 | 3 |
About David Surguladze
David Surguladze is a scholar working on Biotechnology, Oncology and Toxicology, having authored 21 papers that have together received 531 indexed citations. Recurring topics across this work include Angiogenesis and VEGF in Cancer (5 papers), Cancer Research and Treatments (4 papers) and Cancer, Hypoxia, and Metabolism (3 papers). The work is most often cited by research in Oncology (290 citations), Immunology (146 citations) and Cancer Research (78 citations). David Surguladze has collaborated with scholars based in United States and Belgium. Frequent co-authors include Ruslan D. Novosiadly, Gregory D. Plowman, Stephen Castaneda, Kyla Driscoll, Gerald E. Hall, Yanxia Li, Philip W. Iversen, Karim A. Benhadji, Rikke Holmgaard and Xiaohong Xu. Their work appears in journals such as Cancer Research, Clinical Cancer Research and Biochemical and Biophysical Research Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.